• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Dihydrocytochalasin B

Dihydrocytochalasin B

Product ID D3429
Cas No. 39156-67-7
Purity ≥98%
Product Unit SizeCostQuantityStock
0.1 mg $38.00 Please Inquire
1 mg $220.70 In stock
5 mg $909.70 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Dihydrocytochalasin B is a mycotoxin derivative that inhibits actin polymerization, preventing mitosis. Dihydrocytochalasin B exhibits anti-parasitic activity, inhibiting the growth of Entamoeba invadens. Additionally, dihydrocytochalasin B exhibits neuromodulatory activity, enhancing the conversion of Kv1.1 K+ channels to A-type K+ channels.

Product Info

Cas No.

39156-67-7

Purity

≥98%

Formula

C29H39NO5

Formula Wt.

481.62

Melting Point

203-205°C

Solubility

Acetone, DMSO, 100% Ethanol, Methanol

Appearance

White Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

D3429 MSDS PDF

Info Sheet

D3429 Info Sheet PDF

References

Makioka A, Kumagai M, Kobayashi S, et al. Different effects of cytochalasins on the growth and differentiation of Entamoeba invadens. Parasitol Res. 2004 May;93(1):68-71. PMID: 15103555.

Reshetnikova G, Barkan R, Popov B, et al. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Exp Cell Res. 2000 Aug 25;259(1):35-53. PMID: 10942577.

Jing J, Chikvashvili D, Singer-Lahat D, et al. Fast inactivation of a brain K+ channel composed of Kv1.1 and Kvbeta1.1 subunits modulated by G protein beta gamma subunits. EMBO J. 1999 Mar 1;18(5):1245-56. PMID: 10064591.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A4944

    Amlexanox

    Azoxanthone derivative; S100A12 and S100A13 inhibi...
    ≥98%
  • F3208

    Fibrinopeptide B, human

    Antimicrobial peptide, generated during fibrin for...
    ≥95%
  • M5876

    Motesanib

    VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
    ≥98%
  • P3600

    PJ34 Hydrochloride

    PARP inhibitor; potential Pim1 inhibitor.
    ≥95%
  • F4482

    Fluvastatin Sodium

    Statin; HMG-CoA reductase inhibitor, potential Rho...
    ≥98%
  • T1605

    Tebuconazole

    Triazole; 14-α demethylase inhibitor, voltage-gat...
    ≥98%
  • A7868

    Atropine

    Tropane alkaloid found in plants in the Solanaceae...
    ≥98%
  • D3322

    Diflunisal

    NSAID; COX-1/2 inhibitor.
    ≥98%
  • P9668

    Pyrantel Pamoate

    Mixture of pyrantel, a thiophene, and pamoic acid,...
    ≥98%
  • S6018

    Spectinomycin Dihydrochloride Pentahydrate

    Aminocyclitol; protein synthesis inhibitor.
    ≥603 µg/mg (potency)
  • R4132

    RKI-1447

    ROCK1/2 inhibitor.
    ≥98%
  • M5877

    Motesanib Diphosphate

    VEGFR, PDGFR, c-Kit, RET inhibitor.
    ≥98%
  • P2002

    PF-04691502 Dihydrate

    PI3K and mTOR inhibitor.
    ≥98%
  • M4200

    MK-0752

    γ-Secretase inhibitor.
    ≥98%
  • P0001

    P1 Peptide

    Octapeptide, prevents EGFR-PLCγ association.
    ≥95%
  • B6810

    [Hyp3]-Bradykinin

    Natriuretic, vasodilatory peptide, bradykinin anal...
    ≥95%
  • A9708

    AZD-1208

    Pim-1 inhibitor.
    ≥98%
  • A4848

    Amyloid-β (1-40)

    Endogenous APP peptide cleavage product, primary c...
    ≥98%
  • V0145

    Valinomycin

    Peptide, neutral ionophore.
    ≥98%
  • A6234

    Apigenin

    Flavonoid found in various plant sources; GABA-A p...
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only